•  
  •  
  •  
  •  

2025-09-02 17:51:17

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Emerald Finance Ltd and Eclat Net Advisors Pvt Ltd disburse gold loans worth Rs. 40 crores
  • RIR Power Electronics Ltd receives capital subsidy from Odisha Government for SiC Plant
  • DEE Development Engineers Ltd receives LoI from Indian PSU
  • Zaggle Partners with Standard Chartered Bank to Redefine Corporate Spend Management with its Prepaid Card Solutions
  • Marsons Limited receives order worth Rs. 27.35 crores

Keywords Selected:  INE089A01023

Research

  • Dr. Reddy's Laboratories - Analyst Meet Update - Multiple growth initiatives - BUY

Stock Report

  • Aurigene Oncology Ltd announces promising results of Phase 1 study for India's first trial for novel autologous CAR-T cell therapy for multiple myeloma
  • Dr. Reddy's signs voluntary licensing agreement with Gilead Sciences to manufacture and commercialise Lenacapavir in India and other countries
  • Dr. Reddy's Laboratories Ltd receives order from COFEPRIS
  • Dr. Reddy's receives positive CHMP opinion from European Medicines Agency for its proposed Rituximab biosimilar
  • Dr. Reddy's signs non-exclusive patent licensing agreement with Takeda to commercialise Vonoprazan
  • Zydus and Dr. Reddy's announce licensing agreement for co‐marketing of Pertuzumab biosimilar
  • Dr. Reddy's to acquire Nicotinell and related portfolio
  • LIC increases stake in Dr. Reddys Laboratories Ltd
  • Dr. Reddy's Laboratories Limited gets Form 483 from USFDA with 4 observations for API facility
  • Aurigene Pharmaceutical Services Ltd opens biologics facility in Genome Valley, Hyderabad
  • Dr. Reddy's Laboratories Limited recommends final dividend of Rs. 40
  • Dr. Reddy's Laboratories announces the launch of Doxycycline Capsules, 40 mg* in the U.S.
  • Nestlé India and Dr. Reddy's to form joint venture to take health science nutraceutical portfolio to consumers across India and other agreed territories
  • Dr. Reddy's launches Condition Management programme 'DailyBloom™ IBS'
  • Dr. Reddy's launches drug-free migraine management device Nerivio® in Europe following successful launch in India
  • Bayer and Dr. Reddy's sign a marketing and distribution agreement for second brand of Vericiguat™ in India
  • Dr. Reddy's enters into exclusive distribution partnership with Sanofi Healthcare India Pvt Ltd for their vaccine brands in India
  • Dr. Reddy's and Pharmazz, Inc. enter into licensing agreement to market first-in-class Centhaquine for hypovolemic shock in India
  • Dr. Reddy's Laboratories launches Versavo® in the UK
  • Dr. Reddy's announces the acquisition of MenoLabs®, a leading women's health and dietary supplements portfolio of brands
  • Dr. Reddy's Laboratories, Inc. acquires Preferred A-1 shares of Edity Therapeutics Ltd
  • Dr. Reddy's becomes first Indian pharma company to debut on the Dow Jones Sustainability World Index
  • Dr. Reddy's Laboratories Ltd gets 3 observations from USFDA for R&D Centre
  • Dr. Reddy's Laboratories SA enters into agreement for COYA 302

Latest Post

  • Emerald Finance Ltd and Eclat Net Advisors Pvt Ltd disburse gold loans worth Rs. 40 crores
  • RIR Power Electronics Ltd receives capital subsidy from Odisha Government for SiC Plant
  • DEE Development Engineers Ltd receives LoI from Indian PSU
  • Zaggle Partners with Standard Chartered Bank to Redefine Corporate Spend Management with its Prepaid Card Solutions
  • Marsons Limited receives order worth Rs. 27.35 crores


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024